Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Pharmaceuticals Market

PRODUCT TITLE PUBLISHED
European Oral Drug Delivery Market European Oral Drug Delivery Market
The European Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $16.9 billion in 2013 and expected to be $24.6 billion by 2018, growing at a CAGR of 7.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian Oral Drug Delivery Market Asian Oral Drug Delivery Market
The Asian Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $10.9 billion in 2013 and expected to be $19.8 billion by 2018, growing at a CAGR of 12.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
North American Nasal Drug Delivery Market North American Nasal Drug Delivery Market
The North American Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.49 billion in 2013 and expected to be $6.62 billion by 2018, growing at a CAGR of 8.1%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
European Nasal Drug Delivery Market European Nasal Drug Delivery Market
The European Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.95 billion in 2013 and expected to be $4.14 billion by 2018, growing at a CAGR of 7.0%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
Asian Nasal Drug Delivery Market Asian Nasal Drug Delivery Market
The Asian Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.51 billion in 2013 and expected to be $2.69 billion by 2018, growing at a CAGR of 12.2%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
North American Transmucosal Drug Delivery Market North American Transmucosal Drug Delivery Market
The North American Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.26 billion in 2013 and expected to be $1.70 billion by 2018, growing at a CAGR of 6.2%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
European Transmucosal Drug Delivery Market European Transmucosal Drug Delivery Market
The European Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.81 billion in 2013 and expected to be $1.07 billion by 2018, growing at a CAGR of 5.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Asian Transmucosal Drug Delivery Market Asian Transmucosal Drug Delivery Market
The Asian Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.48 billion in 2013 and expected to be $0.72 billion by 2018, growing at a CAGR of 8.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Asian Topical Drug Delivery Market Asian Topical Drug Delivery Market
The Asian Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.54 billion in 2013 and expected to be $2.10 billion by 2018, growing at a CAGR of 6.4%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
European Topical Drug Delivery Market European Topical Drug Delivery Market
The European Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.64 billion in 2013 and expected to be $2.96 billion by 2018, growing at a CAGR of 2.3%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
North American Topical Drug Delivery Market North American Topical Drug Delivery Market
The North American Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.23 billion in 2013 and expected to be $4.90 billion by 2018, growing at a CAGR of 3.0%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
Israel Biopharmaceuticals Israel Biopharmaceuticals
The Israel bio-pharma research market is expected to grow at a CAGR of 7.4% to reach USD 659.2 million by 2020. Increasing number of pharmaceutical and biotechnology start-ups, government support, availability of sufficient venture capital (VC) funds, and availability of skilled, educated, and diverse workforce are the major factors driving the Israel medical devices market. However, government regulations (such as drug pricing) are the major factors restraining the growth of this market.
Nov 2015
812 reports | Show
Connect With Us
US/CAN : +1-888-502-0539